Article Details

Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $57.00 Price Target at Morgan Stanley

Retrieved on: 2021-03-05 09:38:05

Tags for this article:

Click the tags to see associated articles and topics

Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $57.00 Price Target at Morgan Stanley. View article details on hiswai:

Excerpt

WINTON GROUP Ltd bought a new stake in shares of Rhythm Pharmaceuticals during the third quarter valued at about $285,000. Steward Partners ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up